BALDACCI, Erminia
 Distribuzione geografica
Continente #
NA - Nord America 2.383
AS - Asia 1.583
EU - Europa 984
SA - Sud America 272
AF - Africa 55
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.283
Nazione #
US - Stati Uniti d'America 2.338
SG - Singapore 633
IT - Italia 392
CN - Cina 268
HK - Hong Kong 218
BR - Brasile 215
VN - Vietnam 194
DE - Germania 135
IN - India 122
SE - Svezia 121
FI - Finlandia 49
FR - Francia 45
RU - Federazione Russa 42
JP - Giappone 31
AR - Argentina 27
GB - Regno Unito 27
RO - Romania 27
AT - Austria 25
BG - Bulgaria 22
NL - Olanda 22
CA - Canada 20
ZA - Sudafrica 19
UA - Ucraina 16
MX - Messico 15
ID - Indonesia 14
BD - Bangladesh 13
BE - Belgio 13
IQ - Iraq 12
PK - Pakistan 12
TR - Turchia 12
IE - Irlanda 11
PL - Polonia 11
EC - Ecuador 8
ES - Italia 7
MA - Marocco 7
PH - Filippine 7
TG - Togo 7
UZ - Uzbekistan 7
CL - Cile 5
LT - Lituania 5
MY - Malesia 5
UY - Uruguay 5
CI - Costa d'Avorio 4
EG - Egitto 4
KZ - Kazakistan 4
LV - Lettonia 4
AM - Armenia 3
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
CO - Colombia 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KR - Corea 3
NG - Nigeria 3
PA - Panama 3
PE - Perù 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
MM - Myanmar 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TH - Thailandia 2
TW - Taiwan 2
VE - Venezuela 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 5.283
Città #
Singapore 353
Ashburn 269
Dallas 258
San Jose 228
Hong Kong 213
Chandler 141
Fairfield 136
Los Angeles 91
Santa Clara 88
Beijing 80
Rome 72
Ho Chi Minh City 68
Wilmington 58
San Paolo di Civitate 57
Woodbridge 55
Munich 53
Misterbianco 51
Cambridge 50
Seattle 48
Houston 44
Hanoi 43
The Dalles 43
Buffalo 42
Princeton 42
Roseto degli Abruzzi 42
Hillsboro 37
Millbury 36
Frankfurt am Main 34
Lawrence 31
Plano 30
New York 29
Lauterbourg 28
Tokyo 25
Cosenza 22
Sofia 22
São Paulo 21
Helsinki 19
Milan 18
Bremen 17
Council Bluffs 17
Turku 17
Naples 15
Andover 14
Ann Arbor 14
Falkenstein 14
Brussels 13
Cesano Maderno 13
San Diego 13
Johannesburg 12
Redondo Beach 12
Vienna 12
Chicago 11
Corropoli 11
Da Nang 11
Moscow 11
Boston 9
Dublin 9
Haiphong 9
Norwalk 9
Orem 9
Bengaluru 8
Denver 8
Jakarta 8
Toronto 8
Baghdad 7
Lomé 7
Tashkent 7
Chennai 6
Guangzhou 6
Lappeenranta 6
Nuremberg 6
Phoenix 6
Stockholm 6
Amsterdam 5
Atlanta 5
London 5
Montevideo 5
Ottawa 5
Shanghai 5
Abidjan 4
Betim 4
Boardman 4
Brooklyn 4
Bắc Ninh 4
Curitiba 4
Hefei 4
Hải Dương 4
Istanbul 4
Madrid 4
Redwood City 4
Riga 4
Rio de Janeiro 4
Tianjin 4
Warsaw 4
Ankara 3
Baku 3
Buenos Aires 3
Cairo 3
Fortaleza 3
Fremont 3
Totale 3.446
Nome #
A Case Of Thrombosis In Congenital Afibrinogenemia: A Physiopathologic And Management Dilemma 200
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 195
A case of thrombosis in congenital afibrinogenemia patient: a physiopathologic and management dilemma 188
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma 172
Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience 150
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 146
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome 146
Plasma vitamin K1 levels in Italian patients receiving oral anticoagulant therapy for mechanical heart prosthesis: a case-control study 142
Direct oral anticoagulants in patients affected by major congenital thrombophilia 140
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 135
Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions 134
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. 120
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity 119
Investigation of Possible Correlation Between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center 113
Right elbow arthropathy in a patient with severe haemophilia A 111
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort 111
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center 109
Congenital FXI deficiency: preliminary results of phenotypic (clinical and laboratory) and genotypic characterization of a case series from a single center 109
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome 109
Congenital FXI Deficiency: Preliminary Results Of Phenotypic (Clinical And Laboratory) And Genotypic Characterization Of A Case Series From A Single Center 107
Retrospective Evaluation of Phenotype and Management of A-hypo-dys-Fibrinogenemia in a Cohort of Italian Patients 105
Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin 103
Inhibitors in Haemophilia A: Experience of A Single Center in The Last 20 Years 99
RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS 99
THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES 98
Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center 97
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center 96
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants 95
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort 93
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients 91
Oral anticoagulant therapy in Italian patients 80 yr of age or older with atrial fibrillation: a pilot study of low vs. standard PT/INR targets. 89
Inhibitors in Hemophilia (HA): experience of a single center in the last 22 years 87
Different regimens of prophylaxis treatment in young severe hemophilia A patients: comparisons on efficacy, FVIII consumption, and therapy compliance 86
Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma 85
Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. 83
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers 81
Prophylaxis treatment in young severe hemophilia A patients: efficacy, FVIII consumption, trough FVIII levels and therapy compliance 81
USE OF ANAGRELIDE IN A COHORT OF PATIENTS FROM THE LAZIO REGION: COMPARISON WITH RECOMMENDATIONS FROM THE ITALIAN GUIDELINES 78
Efficacy and safety of antithrombotic prophylactic therapy with low-molecular-weight heparin (LMWH) after orthopaedic surgery in haemophilia patients 77
The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO-RA 74
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series 73
Pain assessment and management in Italian Haemophilia Centres 73
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up 71
Dental invasive procedures in von willebrand disease (VWD) outpatients treated with high purity VWF/FVIII complex concentrate: experience of a single center 71
null 69
Tapentadol PR for pain syndromes in real life patients with hematological malignancy. 69
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomised trial 64
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience 62
Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization 60
Prevention of dental injuries and management of first-aid procedures in hemophilia A (HA) children: experience of a single center 54
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia 46
null 39
null 37
null 32
Diagnostic Performance of a DOAC Urine Dipstick in Obese Outpatients with Atrial Fibrillation: Comparison with Plasma Concentrations 28
null 18
Baseline Thrombin Generation Test Does Not Predict Thrombotic Events in Acute Leukemia: A Monocentric Prospective Study 15
null 9
Totale 5.443
Categoria #
all - tutte 14.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 12 2
2021/2022367 17 16 29 6 48 37 8 28 24 34 46 74
2022/2023501 81 149 26 60 42 46 13 28 47 0 8 1
2023/2024201 15 37 4 17 21 33 0 0 3 25 31 15
2024/20251.098 17 91 34 55 64 67 59 59 209 84 84 275
2025/20262.624 298 266 257 163 352 102 506 90 259 241 90 0
Totale 5.443